PDS-0102

N/A

Report date: 2023/01/08 14:03:55

Base Information

Drug NamePDS-0102
Drug Alias NamePDS-0102
ClassificationBiologics
Mechanisms of ActionT lymphocyte replacementsImmunosuppressantsImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPds Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesPds Biotechnology Corp
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A